Aspirin may lower the risk of cancer deaths among women and men, according to a new study.
Aspirin response signature identifies a network of genes that correlated with platelet function and heart attack.
A broken down aspirin product has been shwon to block cell death associated with neurodegenerative diseases.
Previous studies have shown the benefits of a dose of aspirin. Now, new findings published in the Journal of Clinical Oncology reveal that a regular dose of aspirin can help reduce the long-term risk of cancer in some who are overweight.
Could over-the-counter aspirin inhibit the aggressive growth of deadly asbestos-related cancer?
New findings published in the journal Laboratory Investigation investigate how this medication may fight off cancer stem cell reproduction that can lead to relapse in some patients.
New findings presented at the 2015 American Thoracic Society International Conference suggest that the progression of emphysema could be slowed by aspirin.
Previous findings have shown that regular use of aspirin or other non-steroidal anti-inflammatory drugs (NSAID) can reduce the risk of colorectal cancer. However, new findings published in JAMA show that some individuals with rare genetic variants do not share the same benefit.
Medical science continues to make incredible head ways in treating and preventing cancer. Now, some health researchers estimate that it's likely that no one under the age of 80 will die of this health problem by 2050.
Aging genes have long been associated with an increased risk of developing cancer. Now, though, scientists have taken a closer look at what might impact gene aging.
Both prescription and non-prescription aspirin can be used for a variety of reasons, for both significant needs as well as everyday use. Here’s what you need to know if you’re a regular user of aspirin.